Outcomes of HIV-infected children with tuberculosis who are started on antiretroviral therapy in Malawi. 2007

C-N Bong, and S C C Chen, and Y-J Jong, and T-S Tok, and C-F Hsu, and E J Schouten, and S D Makombe, and J K-L Yu, and A D Harries
Taiwan Medical Mission, Mzuzu Central Hospital, Mzuzu, Malawi.

METHODS Mzuzu Central Hospital, in the northern region of Malawi, which provides free antiretroviral therapy (ART) to human immunodeficiency virus (HIV) infected adults and children, including those with tuberculosis (TB). OBJECTIVE To compare outcomes in HIV-infected children who have been started on ART because of 1) active TB, 2) a past history of TB in the last 2 years and 3) a non-TB diagnosis. METHODS Retrospective data collection using ART patient master cards and ART patient registers. RESULTS Between July 2004 and September 2006, 439 (11%) children of a total 3908 patients were started on ART. There were 29 with active TB, 56 with a past history of TB in the last 2 years and 354 with a non-TB diagnosis. The three groups were similar in nutritional indices and CD4-lymphocyte percentages. The 6-month probability of survival was 0.86 in the active TB group, 0.94 in the past history of TB group and 0.89 in the non-TB group. 12-month survival probability for the same groups was 0.86, 0.86 and 0.88, respectively. CONCLUSIONS HIV-infected children with active and previous TB who are started on ART have good outcomes that are similar to those of children started on ART due to a non-TB diagnosis.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D008295 Malawi A republic in southern Africa east of ZAMBIA and MOZAMBIQUE. Its capital is Lilongwe. It was formerly called Nyasaland. Nyasaland,Republic of Malawi
D008297 Male Males
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000995 Antitubercular Agents Drugs used in the treatment of tuberculosis. They are divided into two main classes: "first-line" agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and "second-line" drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy. Anti-Tuberculosis Agent,Anti-Tuberculosis Agents,Anti-Tuberculosis Drug,Anti-Tuberculosis Drugs,Antitubercular Agent,Antitubercular Drug,Tuberculostatic Agent,Tuberculostatic Agents,Antitubercular Drugs,Agent, Anti-Tuberculosis,Agent, Antitubercular,Agent, Tuberculostatic,Anti Tuberculosis Agent,Anti Tuberculosis Agents,Anti Tuberculosis Drug,Anti Tuberculosis Drugs,Drug, Anti-Tuberculosis,Drug, Antitubercular

Related Publications

C-N Bong, and S C C Chen, and Y-J Jong, and T-S Tok, and C-F Hsu, and E J Schouten, and S D Makombe, and J K-L Yu, and A D Harries
November 2007, The Southeast Asian journal of tropical medicine and public health,
C-N Bong, and S C C Chen, and Y-J Jong, and T-S Tok, and C-F Hsu, and E J Schouten, and S D Makombe, and J K-L Yu, and A D Harries
December 2012, Public health action,
C-N Bong, and S C C Chen, and Y-J Jong, and T-S Tok, and C-F Hsu, and E J Schouten, and S D Makombe, and J K-L Yu, and A D Harries
September 2012, Pediatrics,
C-N Bong, and S C C Chen, and Y-J Jong, and T-S Tok, and C-F Hsu, and E J Schouten, and S D Makombe, and J K-L Yu, and A D Harries
January 2024, PloS one,
C-N Bong, and S C C Chen, and Y-J Jong, and T-S Tok, and C-F Hsu, and E J Schouten, and S D Makombe, and J K-L Yu, and A D Harries
January 2018, PloS one,
C-N Bong, and S C C Chen, and Y-J Jong, and T-S Tok, and C-F Hsu, and E J Schouten, and S D Makombe, and J K-L Yu, and A D Harries
March 2008, PLoS medicine,
C-N Bong, and S C C Chen, and Y-J Jong, and T-S Tok, and C-F Hsu, and E J Schouten, and S D Makombe, and J K-L Yu, and A D Harries
May 2018, The Pediatric infectious disease journal,
C-N Bong, and S C C Chen, and Y-J Jong, and T-S Tok, and C-F Hsu, and E J Schouten, and S D Makombe, and J K-L Yu, and A D Harries
April 2007, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease,
C-N Bong, and S C C Chen, and Y-J Jong, and T-S Tok, and C-F Hsu, and E J Schouten, and S D Makombe, and J K-L Yu, and A D Harries
July 2007, Bulletin of the World Health Organization,
C-N Bong, and S C C Chen, and Y-J Jong, and T-S Tok, and C-F Hsu, and E J Schouten, and S D Makombe, and J K-L Yu, and A D Harries
September 2002, AIDS (London, England),
Copied contents to your clipboard!